What's next for the weight-loss drug maker?
Shares in Danish biotech Zealand Pharma plunged recently after detailed data on its weight-loss drug survodutide showed much higher patient…
business
MAHA SNAP restrictions on junk food could change spending
Growing pressure to prevent Americans from using federal food aid to buy certain processed or sugary products is creating a…
California IPO Tax Windfall: Factors Complicating the Equation
The iconic Golden Gate Bridge and the stunning San Francisco skyline seen from the Marin Headlands during the vibrant spring…
Biotech IPO window is open, but big pharma M&As set the pace: bankers
Public markets are beginning to reopen for biotech companies after several years of subdued activity. But stronger companies are still…
Fox will buy Roku for $22 billion
The Fox News electronic news ticker reads headlines at the News Corp. building in the Midtown Manhattan area of New…
Rivian CEO Takes Different Approach to Humanoid Robots Than Elon Musk
A humanoid industrial robot is displayed at the humanoid robot data training center in Shougang Park on March 27, 2025…
World Cup travel push has yet to materialize for U.S. companies
The 2026 World Cup is expected to bring a wave of soccer fans from around the world to North America.…
LIV Golf CEO says to take PIF at its word as funding limit approaches
LIV Golf CEO Scott O'Neil told CNBC on Tuesday that as a funding cliff approaches, the organization has to trust…
Shares of weight-loss drug makers plunge 25% as safety data spooks investors
Shares in weight-loss drug maker Zealand Pharma plunged as much as 26% on Monday after new data on its experimental…
'Backrooms' Producer Peter Chernin Thinks Hollywood Needs to Change
For the past week, one conversation has dominated Hollywood executive lunches and studio staff meetings: What's the next “Backrooms”? The…